An active metabolite of docosahexaenoic acid
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

4-oxo Docosahexaenoic Acid

Item No. 21373

Technical Information
Formal Name
4-oxo-5E,7Z,10Z,13Z,16Z,19Z-docosahexaenoic acid
CAS Number
845673-74-7
Synonyms
  • 4-oxo DHA
Molecular Formula
C22H30O3
Formula Weight
Purity
≥90%
Formulation
A 100 µg/ml solution in ethanol
DMF: 50 mg/mlDMSO: 50 mg/mlEthanol: 50 mg/mlPBS (pH 7.2): 0.1 mg/ml
λmax
277 nm
SMILES
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C=C\C(CCC(O)=O)=O
InChi Code
InChI=1S/C22H30O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-21(23)19-20-22(24)25/h3-4,6-7,9-10,12-13,15-18H,2,5,8,11,14,19-20H2,1H3,(H,24,25)/b4-3-,7-6-,10-9-,13-12-,16-15-,18-17+
InChi Key
UHNUULCIKILOHW-PQVBWYSWSA-N
Shipping & Storage Information
Storage
-80°C
Shipping
Dry ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    4-oxo Docosahexaenoic acid is an active metabolite of docosahexaenoic acid (Item No. 90310).1 It is formed from docosahexaenoic acid by 5-lipoxygenase (5-LO). 4-oxo Docosahexaenoic acid is an agonist of peroxisome proliferator-activated receptor γ (PPARγ).2 It induces gene transcription in a reporter assay using COS-1 cells expressing PPARγ (EC50 = ~10 µM). 4-oxo Docosahexaenoic acid (100 µM) decreases the proliferation of MDA-MB-231, BT-549, T47D, and SK-BR-3 breast cancer cells, MCF-10F breast epithelial cells, and increases the proliferation of MCF-7 breast cancer cells.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Chen, K.-M., Thompson, H., Vanden-Heuvel, J.P., et alLipoxygenase catalyzed metabolites derived from docosahexaenoic acid are promising antitumor agents against breast cancer. Sci. Rep. 11(1), 410 (2021).

    2. Itoh, T., Fairall, L., Amin, K., et alStructural basis for the activation of PPARγ by oxidized fatty acids. Nat. Struct. Mol. Biol. 15(9), 924-931 (2008).

    3. Pogash, T.J., El-Bayoumy, K., Amin, S., et alOxidized derivative of docosahexaenoic acid preferentially inhibit cell proliferation in triple negative over luminal breast cancer cells. In Vitro Cell. Dev. Biol. Anim. 51(2), 121-127 (2015).